Employees Retirement System of Texas Has $9.85 Million Holdings in Agilent Technologies, Inc. (A)
Employees Retirement System of Texas lessened its stake in Agilent Technologies, Inc. (NYSE:A) by 34.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 166,000 shares of the medical research company’s stock after selling 88,000 shares during the period. Employees Retirement System of Texas owned about 0.05% of Agilent Technologies worth $9,845,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. BlackRock Inc. boosted its stake in shares of Agilent Technologies by 1,946.9% in the 1st quarter. BlackRock Inc. now owns 23,119,219 shares of the medical research company’s stock valued at $1,222,310,000 after purchasing an additional 21,989,739 shares during the last quarter. JPMorgan Chase & Co. raised its stake in Agilent Technologies by 45.2% during the second quarter. JPMorgan Chase & Co. now owns 12,145,610 shares of the medical research company’s stock worth $720,358,000 after buying an additional 3,779,099 shares during the last quarter. MARSHALL WACE ASIA Ltd bought a new position in Agilent Technologies during the first quarter worth $58,065,000. Marshall Wace North America L.P. bought a new position in Agilent Technologies during the first quarter worth $58,065,000. Finally, PNC Financial Services Group Inc. raised its stake in Agilent Technologies by 720.6% during the second quarter. PNC Financial Services Group Inc. now owns 1,131,276 shares of the medical research company’s stock worth $67,097,000 after buying an additional 993,414 shares during the last quarter.
Several equities research analysts recently commented on A shares. BidaskClub cut Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 12th. Janney Montgomery Scott lifted their target price on Agilent Technologies from $65.00 to $70.00 and gave the stock a “buy” rating in a report on Wednesday, August 16th. J P Morgan Chase & Co reissued an “overweight” rating and issued a $70.00 price target on shares of Agilent Technologies in a research note on Wednesday, August 16th. Goldman Sachs Group, Inc. (The) reissued a “neutral” rating and issued a $68.00 price target on shares of Agilent Technologies in a research note on Tuesday, September 26th. Finally, Cowen and Company restated a “hold” rating and set a $65.00 price target on shares of Agilent Technologies in a report on Thursday. Four analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Agilent Technologies has an average rating of “Buy” and an average target price of $64.38.
In other news, insider Patrick Kaltenbach sold 5,000 shares of Agilent Technologies stock in a transaction that occurred on Thursday, July 13th. The shares were sold at an average price of $61.26, for a total transaction of $306,300.00. Following the completion of the transaction, the insider now directly owns 45,138 shares in the company, valued at $2,765,153.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Didier Hirsch sold 15,555 shares of Agilent Technologies stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $66.00, for a total transaction of $1,026,630.00. Following the transaction, the chief financial officer now owns 178,557 shares of the company’s stock, valued at $11,784,762. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 170,720 shares of company stock worth $10,795,039.
Agilent Technologies, Inc. (A) traded up 1.20% on Monday, hitting $64.84. 193,269 shares of the company’s stock were exchanged. The firm has a 50 day moving average price of $62.75 and a 200-day moving average price of $58.31. The stock has a market cap of $20.87 billion, a P/E ratio of 33.44 and a beta of 1.30. Agilent Technologies, Inc. has a 52-week low of $42.92 and a 52-week high of $66.45.
Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Tuesday, August 15th. The medical research company reported $0.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.52 by $0.07. The business had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.09 billion. Agilent Technologies had a return on equity of 16.95% and a net margin of 14.36%. The firm’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.49 earnings per share. Analysts predict that Agilent Technologies, Inc. will post $2.32 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 25th. Stockholders of record on Tuesday, October 3rd will be issued a dividend of $0.132 per share. This represents a $0.53 dividend on an annualized basis and a dividend yield of 0.82%. The ex-dividend date of this dividend is Monday, October 2nd. Agilent Technologies’s dividend payout ratio (DPR) is presently 27.32%.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.